Suchergebnisse - "Receptors, Dopamine D2 agonists"

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

Autoren: de Leeuw van Weenen, J. E. Parlevliet, E. T. Maechler, Pierre et al.

Weitere Verfasser: de Leeuw van Weenen, J. E. Parlevliet, E. T. Maechler, Pierre et al.

Quelle: Biochemical Pharmacology, Vol. 79, No 12 (2010) pp. 1827-1836
Biochemical Pharmacology, 79(12), pp. 1827-1836.

Schlagwörter: Male, 0301 basic medicine, Biomedical Research, Bromocriptine/*pharmacology, animal cell, Western blotting, Mice, Insulin-Secreting Cells, Insulin Secretion, α2-Adrenergic receptor, Insulin-Secreting Cells/*drug effects/metabolism, Insulin, insulin release, yohimbine, glucose, bromocriptine, analytic method, 0303 health sciences, Insulin/*secretion, Insulin secretion, drug effect, article, cell line, Glucose/pharmacology, 3. Good health, priority journal, Dopamine Agonists, cell membrane depolarization, dopamine 2 receptor stimulating agent, insulin, Bromocriptine Insulin secretion Mice INS-1E cells Dopamine receptor alpha 2-Adrenergic receptor rat pancreatic-islets obese zucker rats induced hyperglycemia knockout mice diabetic-rats body-weight release hypothalamus homeostasis diazoxide, in vitro study, pancreas islet beta cell, Receptors, Adrenergic, alpha/*metabolism, animal experiment, G protein coupled receptor, glucose tolerance test, Cell Line, in vivo study, 03 medical and health sciences, male, inhibition kinetics, domperidone, Animals, cyclic AMP, controlled study, Dopamine Agonists/*pharmacology, ddc:612, mouse, Bromocriptine, nonhuman, Dose-Response Relationship, Drug, Receptors, Dopamine D2, glucose clamp technique, INS-1E cells, Receptors, Dopamine D2/*agonists, Receptors, Adrenergic, alpha, Rats, Mice, Inbred C57BL, cell membrane potential, Glucose, Dopamine receptor, alpha 2 adrenergic receptor, placebo, Insulinoma, hyperglycemia

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/20138024
http://www.sciencedirect.com/science/article/pii/S0006295210000675
https://core.ac.uk/display/85549819
https://archive-ouverte.unige.ch/unige:20882
https://europepmc.org/abstract/MED/20138024
https://www.ncbi.nlm.nih.gov/pubmed/20138024
https://www.sciencedirect.com/science/article/pii/S0006295210000675
https://hdl.handle.net/1887/109207
https://hdl.handle.net/1887/119293
https://pure.amsterdamumc.nl/en/publications/dae33b13-10a2-4bd0-9dbf-1540cb4b30df
https://doi.org/10.1016/j.bcp.2010.01.029
https://archive-ouverte.unige.ch/unige:20882
https://resolver.tno.nl/uuid:f868c2bb-e03c-4511-b8f2-fb6d63feb87a

Motor Response to a Dopamine D3 Receptor Preferring Agonist Compared to Apomorphine in Levodopa-Primed 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Monkeys

Autoren: Blanchet, P. J. Konitsiotis, S. Chase, T. N.

Quelle: The Journal of Pharmacology and Experimental Therapeutics. 283:794-799

Schlagwörter: Male, Levodopa/*pharmacology, Apomorphine, Receptors, Dopamine D2, Receptors, Dopamine D1, Antiparkinson Agents/pharmacology, Receptors, Dopamine D1/drug effects, Receptors, Dopamine D2/*agonists/drug effects, Receptors, Dopamine D3, MPTP Poisoning, Apomorphine/*pharmacology, Motor Activity, Dopamine Agonists/*pharmacology/toxicity, 3. Good health, Antiparkinson Agents, Levodopa, Motor Activity/*drug effects, 03 medical and health sciences, Macaca fascicularis, 0302 clinical medicine, Dopamine Agonists, Animals, Female

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/9353400
http://olympias.lib.uoi.gr/jspui/handle/123456789/19912